SU‐E‐T‐638: Treatment Margins Expansion for CyberKnife Treatment Plans

Purpose: The CyberKnife uses an online prediction model to track moving targets. The system works well if patients can breathe regularly. However, some patients cannot maintain a regular breathing pattern, which means a larger PTV margin is necessary for these patients to ensure sufficient CTV dose...

Full description

Saved in:
Bibliographic Details
Published inMedical Physics Vol. 39; no. 6; pp. 3852 - 3853
Main Authors Fan, J, Chen, X, Koren, S, Jin, L, Chen, L, Price, R, Wang, L, Hayes, S, Tam, T, Ma, C
Format Conference Proceeding Journal Article
LanguageEnglish
Published United States American Association of Physicists in Medicine 01.06.2012
Subjects
Online AccessGet full text
ISSN0094-2405
2473-4209
2473-4209
DOI10.1118/1.4735727

Cover

Abstract Purpose: The CyberKnife uses an online prediction model to track moving targets. The system works well if patients can breathe regularly. However, some patients cannot maintain a regular breathing pattern, which means a larger PTV margin is necessary for these patients to ensure sufficient CTV dose coverage. However, it is very difficult to predict a patient's breathing pattern in advance. The purpose of this study is to investigate a quick and easy way to adapt the treatment plan if extra margins are needed. Methods: Multiple algorithms have been developed to calculate the adjustment. Generally, if a larger target region requires coverage by the prescription dose, the size of the beams will be larger and they should move in a peripheral direction for a certain distance to avoid hot spots. Dose is recalculated and renormalized consistently after the adjustment. If the dose distribution of the new plan covers the new PTV with acceptable conformality and coverage, the plan will be used for treatment. Otherwise, more iterations of the adjustment are performed. Dose calculations are limited to a small region surrounding the target to reduce calculation time. Results: 5 clinical cases (3 lungs, 1 liver and 1 adrenal) have been tested in this study. The dose margin can be extended up to 10 mm without changing dose distributions around the target region dramatically. The average PTV coverage is 98.7% compared to 99.1% in the original plans and the average CI is 1.22, which is slightly less than the 1.24 in the original plans. Conclusions: Treatment margins can be sufficiently expanded resulting in satisfactory plan quality for patients with breathing irregularities.
AbstractList Purpose: The CyberKnife uses an online prediction model to track moving targets. The system works well if patients can breathe regularly. However, some patients cannot maintain a regular breathing pattern, which means a larger PTV margin is necessary for these patients to ensure sufficient CTV dose coverage. However, it is very difficult to predict a patient's breathing pattern in advance. The purpose of this study is to investigate a quick and easy way to adapt the treatment plan if extra margins are needed. Methods: Multiple algorithms have been developed to calculate the adjustment. Generally, if a larger target region requires coverage by the prescription dose, the size of the beams will be larger and they should move in a peripheral direction for a certain distance to avoid hot spots. Dose is recalculated and renormalized consistently after the adjustment. If the dose distribution of the new plan covers the new PTV with acceptable conformality and coverage, the plan will be used for treatment. Otherwise, more iterations of the adjustment are performed. Dose calculations are limited to a small region surrounding the target to reduce calculation time. Results: 5 clinical cases (3 lungs, 1 liver and 1 adrenal) have been tested in this study. The dose margin can be extended up to 10 mm without changing dose distributions around the target region dramatically. The average PTV coverage is 98.7% compared to 99.1% in the original plans and the average CI is 1.22, which is slightly less than the 1.24 in the original plans. Conclusions: Treatment margins can be sufficiently expanded resulting in satisfactory plan quality for patients with breathing irregularities.
The CyberKnife uses an online prediction model to track moving targets. The system works well if patients can breathe regularly. However, some patients cannot maintain a regular breathing pattern, which means a larger PTV margin is necessary for these patients to ensure sufficient CTV dose coverage. However, it is very difficult to predict a patient's breathing pattern in advance. The purpose of this study is to investigate a quick and easy way to adapt the treatment plan if extra margins are needed.PURPOSEThe CyberKnife uses an online prediction model to track moving targets. The system works well if patients can breathe regularly. However, some patients cannot maintain a regular breathing pattern, which means a larger PTV margin is necessary for these patients to ensure sufficient CTV dose coverage. However, it is very difficult to predict a patient's breathing pattern in advance. The purpose of this study is to investigate a quick and easy way to adapt the treatment plan if extra margins are needed.Multiple algorithms have been developed to calculate the adjustment. Generally, if a larger target region requires coverage by the prescription dose, the size of the beams will be larger and they should move in a peripheral direction for a certain distance to avoid hot spots. Dose is recalculated and renormalized consistently after the adjustment. If the dose distribution of the new plan covers the new PTV with acceptable conformality and coverage, the plan will be used for treatment. Otherwise, more iterations of the adjustment are performed. Dose calculations are limited to a small region surrounding the target to reduce calculation time.METHODSMultiple algorithms have been developed to calculate the adjustment. Generally, if a larger target region requires coverage by the prescription dose, the size of the beams will be larger and they should move in a peripheral direction for a certain distance to avoid hot spots. Dose is recalculated and renormalized consistently after the adjustment. If the dose distribution of the new plan covers the new PTV with acceptable conformality and coverage, the plan will be used for treatment. Otherwise, more iterations of the adjustment are performed. Dose calculations are limited to a small region surrounding the target to reduce calculation time.5 clinical cases (3 lungs, 1 liver and 1 adrenal) have been tested in this study. The dose margin can be extended up to 10 mm without changing dose distributions around the target region dramatically. The average PTV coverage is 98.7% compared to 99.1% in the original plans and the average CI is 1.22, which is slightly less than the 1.24 in the original plans.RESULTS5 clinical cases (3 lungs, 1 liver and 1 adrenal) have been tested in this study. The dose margin can be extended up to 10 mm without changing dose distributions around the target region dramatically. The average PTV coverage is 98.7% compared to 99.1% in the original plans and the average CI is 1.22, which is slightly less than the 1.24 in the original plans.Treatment margins can be sufficiently expanded resulting in satisfactory plan quality for patients with breathing irregularities.CONCLUSIONSTreatment margins can be sufficiently expanded resulting in satisfactory plan quality for patients with breathing irregularities.
The CyberKnife uses an online prediction model to track moving targets. The system works well if patients can breathe regularly. However, some patients cannot maintain a regular breathing pattern, which means a larger PTV margin is necessary for these patients to ensure sufficient CTV dose coverage. However, it is very difficult to predict a patient's breathing pattern in advance. The purpose of this study is to investigate a quick and easy way to adapt the treatment plan if extra margins are needed. Multiple algorithms have been developed to calculate the adjustment. Generally, if a larger target region requires coverage by the prescription dose, the size of the beams will be larger and they should move in a peripheral direction for a certain distance to avoid hot spots. Dose is recalculated and renormalized consistently after the adjustment. If the dose distribution of the new plan covers the new PTV with acceptable conformality and coverage, the plan will be used for treatment. Otherwise, more iterations of the adjustment are performed. Dose calculations are limited to a small region surrounding the target to reduce calculation time. 5 clinical cases (3 lungs, 1 liver and 1 adrenal) have been tested in this study. The dose margin can be extended up to 10 mm without changing dose distributions around the target region dramatically. The average PTV coverage is 98.7% compared to 99.1% in the original plans and the average CI is 1.22, which is slightly less than the 1.24 in the original plans. Treatment margins can be sufficiently expanded resulting in satisfactory plan quality for patients with breathing irregularities.
Author Tam, T
Chen, L
Ma, C
Wang, L
Price, R
Jin, L
Chen, X
Koren, S
Hayes, S
Fan, J
Author_xml – sequence: 1
  givenname: J
  surname: Fan
  fullname: Fan, J
  organization: Fox Chase Cancer Center, Philadelphia, PA
– sequence: 2
  givenname: X
  surname: Chen
  fullname: Chen, X
  organization: Fox Chase Cancer Center, Philadelphia, PA
– sequence: 3
  givenname: S
  surname: Koren
  fullname: Koren, S
  organization: Fox Chase Cancer Center, Philadelphia, PA
– sequence: 4
  givenname: L
  surname: Jin
  fullname: Jin, L
  organization: Fox Chase Cancer Center, Philadelphia, PA
– sequence: 5
  givenname: L
  surname: Chen
  fullname: Chen, L
  organization: Fox Chase Cancer Center, Philadelphia, PA
– sequence: 6
  givenname: R
  surname: Price
  fullname: Price, R
  organization: Fox Chase Cancer Center, Philadelphia, PA
– sequence: 7
  givenname: L
  surname: Wang
  fullname: Wang, L
  organization: Fox Chase Cancer Center, Philadelphia, PA
– sequence: 8
  givenname: S
  surname: Hayes
  fullname: Hayes, S
  organization: Fox Chase Cancer Center, Philadelphia, PA
– sequence: 9
  givenname: T
  surname: Tam
  fullname: Tam, T
  organization: Fox Chase Cancer Center, Philadelphia, PA
– sequence: 10
  givenname: C
  surname: Ma
  fullname: Ma, C
  organization: Fox Chase Cancer Center, Philadelphia, PA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28517548$$D View this record in MEDLINE/PubMed
BookMark eNp90MtKw0AUBuBBKvaiC19AslQhOmcumYw7KfWCLRZs18MkmUgkTepMinbnI_iMPokjieJGF4dzFh8_h3-IelVdGYQOAZ8BQHwOZ0xQLojYQQPiz5ARLHtogLFkIWGY99HQuSeMcUQ53kN9EnMQnMUDNH1Yfry9T_ws_EQ0vggW1uhmZaommGn7WFQumLyudeWKugry2gbjbWLsXVXk5hedl17so91cl84cdHuElleTxfgmnN5f344vp2FKKBVhrA3LWcQlSRg2mkotRES1THNNAFPI0oyABi0h4UISk_AoykjGctA6lTGjI3Tc5q5t_bwxrlGrwqWm9D-YeuMUSIyBcEKlp0cd3SQrk6m1LVbabtV3Ax6ctCC1tXPW5D8EsPpqV4Hq2vU2bO1LUZrt31DN5p0_bb1Li0Y3vsB_wj8BY4-G4Q
CODEN MPHYA6
ContentType Conference Proceeding
Journal Article
Copyright American Association of Physicists in Medicine
2012 American Association of Physicists in Medicine
2012 American Association of Physicists in Medicine.
Copyright_xml – notice: American Association of Physicists in Medicine
– notice: 2012 American Association of Physicists in Medicine
– notice: 2012 American Association of Physicists in Medicine.
DBID AAYXX
CITATION
NPM
7X8
DOI 10.1118/1.4735727
DatabaseName CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
PubMed

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Physics
EISSN 2473-4209
EndPage 3853
ExternalDocumentID 28517548
10_1118_1_4735727
MP5727
Genre miscellaneous
Journal Article
GroupedDBID ---
--Z
-DZ
.GJ
0R~
1OB
1OC
29M
2WC
33P
36B
3O-
4.4
476
53G
5GY
5RE
5VS
AAHHS
AANLZ
AAQQT
AASGY
AAXRX
AAZKR
ABCUV
ABEFU
ABFTF
ABJNI
ABLJU
ABQWH
ABTAH
ABXGK
ACAHQ
ACBEA
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACPOU
ACSMX
ACXBN
ACXQS
ADBBV
ADBTR
ADKYN
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AENEX
AEQDE
AEUYR
AFBPY
AFFPM
AHBTC
AIACR
AIAGR
AIURR
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMYDB
ASPBG
BFHJK
C45
CS3
DCZOG
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMB
EMOBN
F5P
G8K
HDBZQ
HGLYW
I-F
KBYEO
LATKE
LEEKS
LOXES
LUTES
LYRES
MEWTI
O9-
OVD
P2P
P2W
PALCI
PHY
RJQFR
RNS
ROL
SAMSI
SUPJJ
SV3
TEORI
TN5
TWZ
USG
WOHZO
WXSBR
XJT
ZGI
ZVN
ZXP
ZY4
ZZTAW
AAHQN
AAIPD
AAMNL
AAYCA
ABDPE
AFWVQ
AITYG
ALVPJ
AAMMB
AAYXX
ADMLS
AEFGJ
AEYWJ
AGHNM
AGXDD
AGYGG
AIDQK
AIDYY
AIQQE
CITATION
LH4
NPM
7X8
ID FETCH-LOGICAL-c2337-8ae4f46592b40ea39a7763a9cfa21031dcd21a1a91b5792eb566d2d4f1aac9843
ISSN 0094-2405
2473-4209
IngestDate Thu Sep 04 16:38:37 EDT 2025
Thu Apr 03 08:17:03 EDT 2025
Wed Oct 01 03:18:13 EDT 2025
Wed Jan 22 17:06:45 EST 2025
Fri Jun 21 00:28:31 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Lungs
Liver
Language English
License http://onlinelibrary.wiley.com/termsAndConditions
http://doi.wiley.com/10.1002/tdm_license_1
2012 American Association of Physicists in Medicine.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c2337-8ae4f46592b40ea39a7763a9cfa21031dcd21a1a91b5792eb566d2d4f1aac9843
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 28517548
PQID 1900125239
PQPubID 23479
PageCount 2
ParticipantIDs pubmed_primary_28517548
crossref_primary_10_1118_1_4735727
scitation_primary_10_1118_1_4735727
proquest_miscellaneous_1900125239
wiley_primary_10_1118_1_4735727_MP5727
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate June 2012
PublicationDateYYYYMMDD 2012-06-01
PublicationDate_xml – month: 06
  year: 2012
  text: June 2012
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Medical Physics
PublicationTitleAlternate Med Phys
PublicationYear 2012
Publisher American Association of Physicists in Medicine
Publisher_xml – name: American Association of Physicists in Medicine
SSID ssj0006350
Score 2.0151126
Snippet Purpose: The CyberKnife uses an online prediction model to track moving targets. The system works well if patients can breathe regularly. However, some...
The CyberKnife uses an online prediction model to track moving targets. The system works well if patients can breathe regularly. However, some patients cannot...
SourceID proquest
pubmed
crossref
wiley
scitation
SourceType Aggregation Database
Index Database
Publisher
StartPage 3852
SubjectTerms Liver
Lungs
Title SU‐E‐T‐638: Treatment Margins Expansion for CyberKnife Treatment Plans
URI http://dx.doi.org/10.1118/1.4735727
https://onlinelibrary.wiley.com/doi/abs/10.1118%2F1.4735727
https://www.ncbi.nlm.nih.gov/pubmed/28517548
https://www.proquest.com/docview/1900125239
Volume 39
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbhMxEB5BKmg5QSkl_Gn5Ebct9djLrrmhEFSVBlVqIuW2sr221EtSpakEnPoIPCNPwnjX62zUFgGH3TiO14n8OePxzDcegDcOteLWYYrayVTYDFNlFKa8csJyx01e2ztGX98fTMThNJu2ucpDdMlS75kf18aV_A-qVEe4-ijZf0A2dkoVVCZ86U4I0_0qxtcuNa2fpSZytrz1EOMxiUSGYSyNY4n-EbVpPRLNfcpbz5cZfiMBcd4yEAfftV188QSYTlOf6WgVN9KYUKO9eRDiPaZRls8Xdt3KenjaCXgIJgfP3WipUa0YlcK7ZRp3tK3rUOQ8Fbgvu6K1OacoTKGunORFc25tWHPpLb9BnvsYBbbnEySTpnUbNpCTjOrBxsdPo6OTuOaS2tQEG4UfFs6QosffxYfXNY8r24l7sElKR8N_WN-p1KrG-D7srIIwk-OI-QO4ZWfbcHcUuBDbcCdg_hCOTia_Ln8O6RrTRcB-SCJWSYA1ibAmBGuygrXTtIZ1Byafh-PBQRqyZKQGOScVQ1nhhPeOa7FvFZcqpzVDSeMU-hwelamQKaYk01ku0WpS4CushGNKGVkI_gh6s_nMPoYEjWKmEIg5fa5FoRyrpGKcWVFkNsc-vGpHsDxrDkMpm01kUbIyDHMfXrZjW5Ko8v4nNbPzi_OSdE-aTBly2YfdZtBjN0iaf0675z68jij86Tve1vjc3KIcHfuXJ3_V3VPYWk3zZ9BbLi7sc9I1l_pFmGi_AWxTdO8
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=proceeding&rft.title=Medical+Physics&rft.atitle=SU%E2%80%90E%E2%80%90T%E2%80%90638%3A+Treatment+Margins+Expansion+for+CyberKnife+Treatment+Plans&rft.au=Fan%2C+J&rft.au=Chen%2C+X&rft.au=Koren%2C+S&rft.au=Jin%2C+L&rft.date=2012-06-01&rft.issn=0094-2405&rft.eissn=2473-4209&rft.volume=39&rft.issue=6&rft.spage=3852&rft.epage=3853&rft_id=info:doi/10.1118%2F1.4735727
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0094-2405&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0094-2405&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0094-2405&client=summon